Clinical trials of vedolizumab did not include sufficient numbers of subjects aged 65+ to determine whether they respond differently from younger subjects.
PREGNANCY
In women with inflammatory bowel disease who are pregnant or attempting conception, we suggest continuing maintenance vedolizumab therapy throughout pregnancy.13
BREASTFEEDING
Mothers with IBD currently on anti-integrins may breastfeed.13